F d'Oleire - Concepedia

Author

F d'Oleire

Also Known As

F D'Oleire, F d'Oleire, F. D'OLEIRE, F. D'Oleire, F. D'oleire, F. D’Oleire, F. d'Oleire, Floriane D'Oleire, Floriane d'Oleire

Publications

507

Citations

H-Index

Concepts

All Affiliations

University of Wisconsin–Madison University of Lübeck Memorial Sloan Kettering Cancer Center University of Wisconsin Carbone Cancer Center

About

F d'Oleire is an author at University of Wisconsin–Madison specializing in medicine, inflammation, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	127
2	Health Sciences	3	3	93
3	Pathology	3	3	73
4	Immunology	2	2	33
5	Pharmacology	2	2	73

F d'Oleire

Publications

443

Citations

H-Index

Page 1

	Year	Citations
Synovial sarcoma of childhood and adolescence. Report of the german CWS-81 study Ruth Ladenstein, Helmut Gadner, Jörn Treuner, Cancer	1993	109
Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients. H. Ian Robins, Daniel A. Rushing, M Kutz, Journal of Clinical Oncology	1997	99
Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients. H. Ian Robins, Justin Cohen, Carol L. Schmitt, Journal of Clinical Oncology	1993	57
Ifosfamide and carboplatin combined with 41.8 degrees C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma. Günther Wiedemann, F d'Oleire, Eduardo Knop, PubMed Surgical OncologyPathologyThermal TherapyPharmacotherapyMetronomic Chemotherapy	1994	50
Lack of thermal enhancement for taxanes<i>in vitro</i> Ron C. Rietbroek, Dörthe M. Katschinski, Monique H. Reijers, International Journal of Hyperthermia	1997	39
Systemic hyperthermia and ICE chemotherapy for sarcoma patients: rationale and clinical status. Günther Wiedemann, H. I. Robins, Dörthe M. Katschinski, PubMed Thermal TherapyPharmacotherapyMetronomic ChemotherapyDermatologyImmunotherapy	1997	31
Cytotoxic interactions of tumor necrosis factor, melphalan and 41.8 °C hyperthermia H. Ian Robins, F d'Oleire, Mathew Kutz, Cancer Letters Inflammation°C HyperthermiaTumor Necrosis FactorHyperthermiaMedicine	1995	23
A pilot study of melphalan, tumor necrosis factor-α and 41.8 °C whole-body hyperthermia H. Ian Robins, Dörthe M. Katschinski, Walter Longo, Cancer Chemotherapy and Pharmacology InflammationHyperthermia°C Whole-body HyperthermiaPhysiologyPathology	1999	13
Hematological effects of radiant heat-induced whole body hyperthermia on dogs. J. Paul Woods, C L Schmitt-Tiggelaar, F d'Oleire, PubMed Animal PhysiologyPutative Wbh-induced PlateletComplete Blood CountsThrombopoiesisVeterinary Physiology	1996	12
Rationale and clinical status of 41.8 degrees C systemic hyperthermia tumor necrosis factor, and melphalan for neoplastic disease. H. Ian Robins, F d'Oleire, E.A. Grosen, PubMed InflammationClinical StatusTumor Necrosis FactorOncologyDramatic Clinical Results	1997	10

Page 1